Abstract: A fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A capable of viral entry inhibition; and/or at least one Cationic AntiMicrobial Peptide, polypeptide C.
Type:
Grant
Filed:
January 9, 2012
Date of Patent:
October 13, 2015
Assignee:
VALIANT BIOPHARMA SDN BHD
Inventors:
Muhammad Sagaf Abu Bakar, Ag., Eng Huan Ung
Abstract: A fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A capable of viral entry inhibition; and/or at least one Cationic AntiMicrobial Peptide, polypeptide C.
Type:
Application
Filed:
January 9, 2012
Publication date:
December 19, 2013
Applicant:
VALIANT BIOPHARMA SDN BHD
Inventors:
Muhammad Sagaf Abu Bakar, Ag., Eng Huan Ung